Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients

References

• Brems C, Johnson ME, Wells RS, Burns R, Kletti N. Rates and sequelae of the coexistence of substance use and other psychiatric disorders. Int J Circumpolar Health. 2002;61:224–244. doi:10.3402/ijch.v61i3.1745612369112
   PubMedGoogle Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Comorbidity of substance use and mental disorders in Europe; 2015 Available from: http://www.emcdda.europa.eu/attachements.cfm/att_245096_EN_TDXD15019ENN.pdf. Accessed 75, 2019.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2010 National Survey on Drug Use and Health: summary of National Findings; 2011 Available from: https://www.samhsa.gov/data/sites/default/files/NSDUHNationalFindingsResults2010-web/2k10ResultsRev/NSDUHresultsRev2010.pdf. Accessed 75, 2019.
   Google Scholar
• Green AI. Schizophrenia and comorbid substance use disorder: effects of antipsychotics. J Clin Psychiatry. 2005;66:21–26.
   PubMed Web of Science ®Google Scholar
• Torrens M, Martínez-Sanvisens D, Martínez-Riera R, Bulbena A, Szerman N, Ruiz P. Dual diagnosis: focusing on depression and recommendations for treatment. Addict Disord Their Treat. 2011;10:50–59. doi:10.1097/ADT.0b013e318215f322
   Google Scholar
• Langås AM, Malt UF, Opjordsmoen S. In-depth study of personality disorders in first-admission patients with substance use disorders. BMC Psychiatry. 2012;12:180. doi:10.1186/1471-244X-12-18023107025
   PubMed Web of Science ®Google Scholar
• Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259–1264.3904487
   PubMed Web of Science ®Google Scholar
• Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4:231–244. doi:10.3109/106732297090305509385000
   PubMed Web of Science ®Google Scholar
• Dervaux A, Baylé FJ, Laqueille X, et al. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? Am J Psychiatry. 2001;158:492–494. doi:10.1176/appi.ajp.158.3.49211229997
   PubMed Web of Science ®Google Scholar
• Goswami S, Mattoo SK, Basu D, Singh G. Substance-abusing schizophrenics: do they self-medicate? Am J Addict. 2004;13:139–150. doi:10.1080/1055049049043579515204665
   PubMed Web of Science ®Google Scholar
• Bizzarri JV, Rucci P, Sbrana A, et al. Substance use in severe mental illness: self-medication and vulnerability factors. Psychiatry Res. 2009;165:88–95. doi:10.1016/j.psychres.2007.10.00919054572
   PubMed Web of Science ®Google Scholar
• Mariani JJ, Khantzian EJ, Levin FR. The self‐medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict. 2014;23:189–193. doi:10.1111/vsu.v23.225187055
   PubMed Web of Science ®Google Scholar
• Pettersen H, Ruud T, Ravndal E, Landheim A. Walking the fine line: self-reported reasons for substance use in persons with severe mental illness. Int J Qual Stud Health Well-Being. 2013;8:21968. doi:10.3402/qhw.v8i0.2196824369778
   PubMed Web of Science ®Google Scholar
• Bizzarri JV, Casetti V, Panzani P, et al. Risky use and misuse of alcohol and cigarettes in psychiatric inpatients: a screening questionnaire study. Compr Psychiatry. 2016;70:9–16. doi:10.1016/j.comppsych.2016.05.01127624418
   PubMed Web of Science ®Google Scholar
• Najt P, Fusar-Poli P, Brambilla P. Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Res. 2011;186:159–164. doi:10.1016/j.psychres.2010.07.04220728943
   PubMed Web of Science ®Google Scholar
• Martins SS, Gorelick DA. Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the US population. Drug Alcohol Depend. 2011;119:28–36. doi:10.1016/j.drugalcdep.2011.05.01021641123
   PubMed Web of Science ®Google Scholar
• Roncero C, Gómez-Baeza S, Vázquez JM, et al. Perception of Spanish professionals on therapeutic adherence of dual diagnosis patients. Actas Esp Psiquiatr. 2013;41:319–329.24203504
   PubMed Web of Science ®Google Scholar
• Pani PP, Trogu E, Vigna-Taglianti F, et al. Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment. Ann Gen Psychiatry. 2014;13:35. doi:10.1186/s12991-014-0035-x25435897
   PubMed Web of Science ®Google Scholar
• Berenz EC, Coffe SF. Treatment of co-occurring posttraumatic stress disorder and substance use disorders. Curr Psychiatry Rep. 2012;14:469–477. doi:10.1007/s11920-012-0300-022825992
   PubMed Web of Science ®Google Scholar
• Sterling S, Chi F, Hinman A. Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions. Alcohol Res Health. 2011;33:338–349.23580018
   PubMedGoogle Scholar
• Di Lorenzo R, Galliani A, Guicciardi A, et al. A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services. Neuropsychiatr Dis Treat. 2014;10:1479–1488. doi:10.2147/NDT.S6589625143738
   PubMed Web of Science ®Google Scholar
• Kêdoté MN, Brousselle A, Champagne F. Use of health care services by patients with co-occurring severe mental illness and substance use disorders. Ment Health Subst Use. 2008;1:216–227. doi:10.1080/1752328080227488627239226
   PubMedGoogle Scholar
• Green CA, Yarborough MT, Polen MR, Janoff SL, Yarborough BJH. Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis. J Dual Diagn. 2015;11:33–41. doi:10.1080/15504263.2014.97500425491440
   PubMed Web of Science ®Google Scholar
• Drake RE, O’Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat. 2008;34:123–138. doi:10.1016/j.jsat.2007.01.01117574803
   PubMed Web of Science ®Google Scholar
• Ziedonis DM, Smelson D, Rosenthal RN, et al. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005;11:315–339. doi:10.1097/00131746-200509000-0000516184072
   PubMedGoogle Scholar
• Dixon LB, Dickerson F, Bellack AS, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36:48–70. doi:10.1093/schbul/sbp11519955389
   PubMed Web of Science ®Google Scholar
• Ness O, Borg M, Davidson L. Facilitators and barriers in dual recovery: a literature review of first-person perspectives. Adv Dual Diagn. 2014;7:107–117. doi:10.1108/ADD-02-2014-0007
   Google Scholar
• Murthy P, Mahadevan J, Chand PK. Treatment of substance use disorders with co-occurring severe mental health disorders. Curr Opin Psychiatry. 2019;32:293–299. doi:10.1097/YCO.000000000000051031157674
   PubMed Web of Science ®Google Scholar
• Milano G, Saenz E, Clark N, et al. Report on the International Workshop on Drug Prevention and Treatment in Rural Settings Organized by United Nation Office on Drugs and Crime (UNODC) and World Health Organization (WHO). Subst Use Misuse. 2017;52:1801–1807. doi:10.1080/10826084.2017.130656428605304
   PubMed Web of Science ®Google Scholar
• Caldwell JT, Ford CL, Wallace SP, Wang MC, Takahashi LM. Intersection of living in a rural versus urban area and race/ethnicity in explaining access to health care in the United States. Am J Public Health. 2016;106:1463–1469. doi:10.2105/AJPH.2016.30321227310341
   PubMed Web of Science ®Google Scholar
• Monnat SM, Rigg KK. Examining rural/urban differences in prescription opioid misuse among US adolescents. J Rural Health. 2016;32:204–218. doi:10.1111/jrh.2016.32.issue-226344571
   PubMed Web of Science ®Google Scholar
• Chasnoff IJ, Telford E, Wells AM, King L. Mental health disorders among children within child welfare who have prenatal substance exposure: rural vs. urban populations. Child Welfare. 2015;94:53–70.
   PubMed Web of Science ®Google Scholar
• ISTAT, National Institute of Statistics. Available from: http://dati.istat.it/Index.aspx?DataSetCode=DCIS_INDDEMOG1#. Accessed 1014, 2019.
   Google Scholar
• ISTAT, National Institute of Statistics. Available from: http://dati.istat.it/Index.aspx?QueryId=18967. Accessed 75, 2019.
   Google Scholar
• Judd FK, Jackson HJ, Komiti A, Murray G, Hodgins G, Fraser C. High prevalence disorders in urban and rural communities. Aust N Z J Psychiatry. 2002;36:104–113. doi:10.1046/j.1440-1614.2002.00986.x11929446
   PubMed Web of Science ®Google Scholar
• Mueser KT, Essock SM, Drake RE, Wolfe RS, Frisman L. Rural and urban differences in patients with a dual diagnosis. Schizophr Res. 2001;48:93–107. doi:10.1016/S0920-9964(00)00065-711278157
   PubMed Web of Science ®Google Scholar
• Browne T, Priester MA, Clone S, Iachini A, DeHart D, Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J Rural Health. 2016;32:92–101. doi:10.1111/jrh.1212926184098
   PubMed Web of Science ®Google Scholar
• Benoit C, McCarthy B, Jansson M. Stigma, sex work, and substance use: a comparative analysis. Sociol Health Illn. 2015;37:437–451. doi:10.1111/shil.2015.37.issue-325688450
   PubMed Web of Science ®Google Scholar
• King R. Science over stigma saving lives—implementation of Naloxone use in the school setting. NASN School Nurse. 2016;31:96–101. doi:10.1177/1942602X1662889026929211
   PubMedGoogle Scholar
• Guerrero EG, Padwa H, Lengnick-Hall R, Kong Y, Perrigo JL. Leadership and licensure for drug treatment and the implementation of co-occurring disorder treatment in community mental health centers. Community Ment Health J. 2015;51:554–566. doi:10.1007/s10597-015-9886-025982830
   PubMed Web of Science ®Google Scholar
• Lozano ÓM, Rojas AJ, Fernández Calderón F. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life? J Ment Health. 2017;26:119–126. doi:10.1080/09638237.2016.117777127128492
   PubMed Web of Science ®Google Scholar
• Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs. 2002;62:743–755. doi:10.2165/00003495-200262050-0000311929329
   PubMed Web of Science ®Google Scholar
• Woo J, Bhalerao A, Bawor M, et al. “Don’t judge a book its cover”: a qualitative study of methadone patients’ experiences of stigma. Subst Abuse. 2017;11:1178221816685087.28469424
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Bobes-Bascaran MT, Bascaran MT, Saiz PA, Bobes J. Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? Br J Clin Pharmacol. 2014;77:272–284. doi:10.1111/bcp.2014.77.issue-223145768
   PubMed Web of Science ®Google Scholar